# Coca Cola Co: overview

KO · NYSE · CIK 21344 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ko.md) · [Financials](/companies/ko/financials.md) · [Filings](/companies/ko/filings.md) · [Insiders](/companies/ko/insiders.md)

Latest reported revenue: [$12.47bn](/filings/0001628280-26-028802.md) for Q1 FY2026, three months to 2026-04-03, from the 10-Q filed Apr 30, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-028802).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.4](/filings/0000021344-25-000061.md) | [11.9](/filings/0001628280-25-046054.md) | [11.5 d](/filings/0001628280-26-010047.md) | [11.1](/filings/0001628280-26-028802.md) | [12.5](/filings/0000021344-25-000061.md) | [12.5](/filings/0001628280-25-046054.md) | [11.8 d](/filings/0001628280-26-010047.md) | [12.5](/filings/0001628280-26-028802.md) |
| Gross margin | % | [61.1%](/filings/0000021344-25-000061.md) | [60.7%](/filings/0001628280-25-046054.md) | [60.0% d](/filings/0001628280-26-010047.md) | [62.6%](/filings/0001628280-26-028802.md) | [62.4%](/filings/0000021344-25-000061.md) | [61.5%](/filings/0001628280-25-046054.md) | [60.0% d](/filings/0001628280-26-010047.md) | [63.0%](/filings/0001628280-26-028802.md) |
| Operating margin | % | [21.3%](/filings/0000021344-25-000061.md) | [21.2%](/filings/0001628280-25-046054.md) | [23.5% d](/filings/0001628280-26-010047.md) | [32.9%](/filings/0001628280-26-028802.md) | [34.1%](/filings/0000021344-25-000061.md) | [32.0%](/filings/0001628280-25-046054.md) | [15.6% d](/filings/0001628280-26-010047.md) | [35.0%](/filings/0001628280-26-028802.md) |
| Net margin | % | [19.5%](/filings/0000021344-25-000061.md) | [24.0%](/filings/0001628280-25-046054.md) | [19.0% d](/filings/0001628280-26-010047.md) | [29.9%](/filings/0001628280-26-028802.md) | [30.4%](/filings/0000021344-25-000061.md) | [29.7%](/filings/0001628280-25-046054.md) | [19.2% d](/filings/0001628280-26-010047.md) | [31.5%](/filings/0001628280-26-028802.md) |
| Diluted EPS | $ per share | [0.56](/filings/0000021344-25-000061.md) | [0.66](/filings/0001628280-25-046054.md) | not reported | [0.77](/filings/0001628280-26-028802.md) | [0.88](/filings/0000021344-25-000061.md) | [0.86](/filings/0001628280-25-046054.md) | not reported | [0.91](/filings/0001628280-26-028802.md) |
| Free cash flow | $bn | [3.2 d](/filings/0000021344-25-000061.md) | [(1.7) d](/filings/0001628280-25-046054.md) | [3.1 d](/filings/0001628280-26-010047.md) | [(5.5)](/filings/0001628280-26-028802.md) | [3.4 d](/filings/0000021344-25-000061.md) | [4.6 d](/filings/0001628280-25-046054.md) | [2.9 d](/filings/0001628280-26-010047.md) | [1.8](/filings/0001628280-26-028802.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [38.7](/filings/0000021344-24-000009.md) | [43.0](/filings/0000021344-25-000011.md) | [45.8](/filings/0001628280-26-010047.md) | [47.1](/filings/0001628280-26-010047.md) | [47.9](/filings/0001628280-26-010047.md) |
| Gross margin | % | [60.3%](/filings/0000021344-24-000009.md) | [58.1%](/filings/0000021344-25-000011.md) | [59.5%](/filings/0001628280-26-010047.md) | [61.1%](/filings/0001628280-26-010047.md) | [61.6%](/filings/0001628280-26-010047.md) |
| Operating margin | % | [26.7%](/filings/0000021344-24-000009.md) | [25.4%](/filings/0000021344-25-000011.md) | [24.7%](/filings/0001628280-26-010047.md) | [21.2%](/filings/0001628280-26-010047.md) | [28.7%](/filings/0001628280-26-010047.md) |
| Net margin | % | [25.3%](/filings/0000021344-24-000009.md) | [22.2%](/filings/0000021344-25-000011.md) | [23.4%](/filings/0001628280-26-010047.md) | [22.6%](/filings/0001628280-26-010047.md) | [27.3%](/filings/0001628280-26-010047.md) |
| Diluted EPS | $ per share | [2.25](/filings/0000021344-24-000009.md) | [2.19](/filings/0000021344-25-000011.md) | [2.47](/filings/0001628280-26-010047.md) | [2.46](/filings/0001628280-26-010047.md) | [3.04](/filings/0001628280-26-010047.md) |
| Free cash flow | $bn | [11.3](/filings/0000021344-24-000009.md) | [9.5](/filings/0000021344-25-000011.md) | [9.7](/filings/0001628280-26-010047.md) | [4.7](/filings/0001628280-26-010047.md) | [5.3](/filings/0001628280-26-010047.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ko/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Berkshire Hathaway Inc](/funds/1067983.md) | 2026-06-30 | $32.51bn | 400,000,000 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $26.23bn | 322,740,471 |  | Reduced −10,856,310 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $19.41bn | 238,798,011 |  | Added +1,345,244 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $13.69bn | 167,399,379 |  | Added +176,984 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $8.87bn | 109,159,806 |  | Added +1,581,872 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.60bn | 105,977,991 |  | Added +13,023,362 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $8.10bn | 99,612,603 |  | Reduced −336,023 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $7.30bn | 89,824,129 |  | Reduced −2,069,941 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $6.57bn | 80,822,520 |  | Added +4,483,481 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $4.59bn | 55,484,687 |  | Reduced −15,107,908 |

## Recent filings

[All 2,480 filings](/companies/ko/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-29 | 14:04 ET | [10-Q](/filings/0001628280-26-050503.md) | Quarterly report, period 2026-07-03 | 0001628280-26-050503 |
| 2026-07-28 | 06:58 ET | [8-K](/filings/0001628280-26-049922.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049922 |
| 2026-07-16 | 16:20 ET | [8-K](/filings/0001628280-26-048466.md) | 8.01 Other events | 0001628280-26-048466 |
| 2026-06-25 | 16:19 ET | [8-K](/filings/0001552781-26-000366.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-26-000366 |
| 2026-05-01 | 14:01 ET | [8-K](/filings/0001628280-26-029230.md) | 5.07 Shareholder vote results | 0001628280-26-029230 |
| 2026-04-30 | 15:17 ET | [10-Q](/filings/0001628280-26-028802.md) | Quarterly report, period 2026-04-03 | 0001628280-26-028802 |
| 2026-04-28 | 07:00 ET | [8-K](/filings/0001628280-26-027723.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-027723 |
| 2026-03-16 | 10:20 ET | [DEF 14A](/filings/0001104659-26-028215.md) | Proxy statement, period 2026-04-29 | 0001104659-26-028215 |
| 2026-02-20 | 10:10 ET | [8-K](/filings/0001628280-26-010052.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-010052 |
| 2026-02-20 | 09:46 ET | [10-K](/filings/0001628280-26-010047.md) | Annual report, period 2025-12-31 | 0001628280-26-010047 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-010047.md), filed Feb 20, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 21344
- Tickers: KO
- Exchange: NYSE
- SIC code: 2080 Beverages
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 06:59 ET. No prices; not investment advice.